Published in Lab Law Weekly, October 21st, 2005
The new product is announced under the trade name Vansolin. The active ingredient is Vancomycin, a very powerful antibiotic used mainly in hospitals to treat life threatening infectious disease such as hospital acquired pneumonia, ventilator associated pneumonia and severe sepsis. Vansolin is the company's fourth product employing nanotechnology, a line of products which are intended to increase the efficacy of the existing base drug compounds while reducing their side effects.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.